|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: TRANSGENOMIC INC, 10-Q, 2000-08-29 |
Next: GE CAPITAL LIFE SEPARATE ACCOUNT II, N-30D, 2000-08-29 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 15,909
<SECURITIES> 0
<RECEIVABLES> 4,797,689
<ALLOWANCES> 208,498
<INVENTORY> 2,090,993
<CURRENT-ASSETS> 10,307,320
<PP&E> 5,009,440
<DEPRECIATION> 1,898,063
<TOTAL-ASSETS> 15,973,056
<CURRENT-LIABILITIES> 10,186,568
<BONDS> 13,072,677
0
0
<COMMON> 130,250
<OTHER-SE> (7,416,439)
<TOTAL-LIABILITY-AND-EQUITY> 15,973,056
<SALES> 12,536,353
<TOTAL-REVENUES> 12,536,353
<CGS> 6,511,520
<TOTAL-COSTS> 11,324,737
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 911,970
<INCOME-PRETAX> (6,211,374)
<INCOME-TAX> 0
<INCOME-CONTINUING> (6,211,374)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (6,211,374)
<EPS-BASIC> (0.48)
<EPS-DILUTED> (0.48)
</TABLE>
|
|